Ninerafaxstat clinical trials
Also written IMB-1018972.
How each study uses ninerafaxstat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ninerafaxstat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- IMB-1018972
- 4
Studies by the year they started
5 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Imbria Pharmaceuticals, Inc. (5)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test ninerafaxstat.
- Dec 2026A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 2 · Imbria Pharmaceuticals, Inc.
Studies
Open first, then newest update. How each study uses ninerafaxstat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyRecruitingPhase 2Imbria Pharmaceuticals, Inc.NCT07023614Written as Ninerafaxstat 200mg MR
- A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory AnginaWithdrawnPhase 2Imbria Pharmaceuticals, Inc.NCT04306237Written as IMB-1018972
- IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)CompletedPhase 2Imbria Pharmaceuticals, Inc.NCT04826159Written as IMB-1018972
- Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)CompletedPhase 2Imbria Pharmaceuticals, Inc.NCT04826172Written as IMB-1018972
- A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy TrialCompletedPhase 2Imbria Pharmaceuticals, Inc.NCT04826185Written as IMB-1018972
Codes
What other systems call ninerafaxstat · ClinicalTrials.gg INT014226
- UNII (FDA) 0RB6V4E5XNNINERAFAXSTATConfirmed FDA, Wikidata
- Wikidata Q123913951ninerafaxstatConfirmed FDA, Wikidata
- NCI Thesaurus C179109NinerafaxstatOne source FDA
- DrugBank DB21486One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 0RB6V4E5XN | NINERAFAXSTAT | Confirmed FDA, Wikidata |
| Wikidata | Q123913951 | ninerafaxstat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C179109 | Ninerafaxstat | One source FDA |
| DrugBank | DB21486 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.